RETRACTED: Daphnetin inhibits proliferation and glycolysis in colorectal cancer cells by regulating the PI3K/Akt signaling pathway (Retracted article. See vol. 11, pg. 5023, 2021)

被引：4
|
作者：
He, Zhikuan [1 ]
Dong, Wenxing [2 ]
Yao, Kunhou [1 ]
Qin, Changjiang [1 ]
Duan, Baomin [2 ]
机构：
[1] Henan Univ, Dept Gen Surg, Huaihe Hosp, Kaifeng 475000, Henan, Peoples R China
[2] Kaifeng Cent Hosp, Dept Emergency, 58 East St, Kaifeng 475000, Henan, Peoples R China
来源：
RSC ADVANCES | 2018年 / 8卷 / 60期
关键词：
AEROBIC GLYCOLYSIS;
D O I：
10.1039/c8ra05583a
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Daphnetin (7,8-dihydroxycoumarin), a natural coumarin compound, has shown antitumor and energy metabolism regulatory activities. However, the effects of daphnetin on cell proliferation, migration, and glucose metabolism in colorectal cancer (CRC) cells remains unknown. In this study, the effects of daphnetin on CRC cell proliferation, migration, and glucose metabolism have been examined. The results showed that daphnetin inhibited the proliferation, migration, and invasion of CRC cells, and induced CRC cell apoptosis. Furthermore, daphnetin suppressed intracellular glucose and lactate production, and downregulated the expression of hexokinase 2 (HK2) and glucose transporter 1 (GLUT1) in CRC cells. Furthermore, daphnetin prevented activation of the PI3K/Akt pathway in CRC cells. These findings demonstrated that daphnetin inhibited the proliferation, migration and glucose metabolism in CRC cells by suppressing the PI3K/Akt signaling pathway. Therefore, daphnetin has potential as a novel anticancer agent for CRC treatment.
引用
收藏
页码：34483 / 34490
页数：8
相关论文
共 50 条
  • [1] RETRACTED: Oxymatrine Inhibits the Proliferation and Invasion of Breast Cancer Cells via the PI3K Pathway (Retracted article. See vol. 14, pg. 2289, 2022)
    Guo, Lin
    Yang, Tengfei
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10499 - 10508
  • [2] RETRACTED: LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway (Retracted article. See vol. 25, pg. 2460, 2021)
    Lei, Y.
    Wang, Y. -H.
    Wang, X. -F.
    Bai, J.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) : 6315 - 6323
  • [3] RETRACTED: MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway (Retracted article. See vol. 24, pg. 7202, 2020)
    Fu, J. -H.
    Yang, S.
    Nan, C. -J.
    Zhou, C. -C.
    Lu, D. -Q.
    Li, S.
    Mu, H. -Q.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (02) : 351 - 357
  • [4] RETRACTED: Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway (Retracted article. See vol. 236, pg. 8257, 2021)
    Liu, Meihan
    Zhang, Jingzhe
    Dong, Hang
    Wang, Wenjun
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 20879 - 20887
  • [5] RETRACTED: FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway (Retracted article. See vol. 25, pg. 2159, 2021)
    Li, Z. -Q.
    Qu, M.
    Wan, H. -X.
    Wang, H.
    Deng, Q.
    Zhang, Y.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 9978 - 9987
  • [6] RETRACTED: Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway (Retracted article. See vol. 21, 2021)
    Ma, Dongjie
    Li, Shanqing
    Cui, Yushang
    Li, Li
    Liu, Hongsheng
    Chen, Yeye
    Zhou, Xiaoyun
    [J]. ONCOLOGY LETTERS, 2018, 15 (05) : 6211 - 6216
  • [7] RETRACTION: Daphnetin inhibits proliferation and glycolysis in colorectal cancer cells by regulating the PI3K/Akt signaling pathway (Retraction of Vol 8, Pg 34483, 2018)
    Fisher, Laura
    [J]. RSC ADVANCES, 2021, 11 (09) : 5023 - 5023
  • [8] RETRACTED: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway (Retracted article. See vol. 11, pg. 5022, 2021)
    Huo, Jun-feng
    Chen, Xiao-bing
    [J]. RSC ADVANCES, 2019, 9 (49) : 28775 - 28782
  • [9] RETRACTED: Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells (Retracted article. See vol. 63, 2023)
    Tian, Feng
    Ding, Ding
    Li, Dandan
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (06) : 2355 - 2363
  • [10] RETRACTED: Knockdown of TMPRSS11D inhibits the proliferation, migration and invasion of cervical cancer cells (Retracted article. See vol. 11, pg. 5239, 2021)
    Yan, Kun
    Hu, Chunyan
    Liu, Chen
    Chu, Guanghua
    Wang, Xinru
    Ma, Shuyun
    Li, Long
    [J]. RSC ADVANCES, 2019, 9 (37) : 21591 - 21600
12345